Search

The article reports on the interferon-based treatments for hepatitis C, an infectious blood-borne virus, in Australia. It details the side effects of interferon-based therapy which prompt people to discontinue its usage. It discusses the treatment for individuals co-infected with hepatitis C and HIV, the experiences of hepatitis C treatment and the importance of an individual's social context in maximizing adherence to such treatment.